Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-07-25
1989-03-07
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 69, A61K 3148, C07D4574
Patent
active
048107107
ABSTRACT:
Method of blocking 5HT without effect on alpha receptors with 1-loweralkyl-6-straight chain alkyl-8.beta.-hydroxycycloalkyloxycarbonylergolines.
REFERENCES:
patent: 3113133 (1963-12-01), Hofmann et al.
patent: 3183234 (1965-05-01), Garbrecht et al.
patent: 3228941 (1966-01-01), Bernardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
patent: 4563461 (1986-01-01), Cohen et al.
Cohen, Drug Development Res., 5, 313 (1985) (Cohen IV).
Cohen et al., J.P.E.T., 232, 770 (1985) (Cohen III).
Berde, The Medical Journal of Australia, Special Supplement, Nov. 4, 1978, pp. 3-13.
Fanciullacci et al., Headache, 16, 226 (1976).
Calesnick, AFP, 25, 228 (1982).
Awouters, 5-Hydroxytryptamine in Perpheral Reactions (Raven Press, N.Y. 1982) pp. 71-75.
Aellig, Eur. J. Clin. Pharm., 25, 759 (1983).
Sulman et al., Headache, 17, 203 (1979).
Amano et al., ibid, 22, 249 (1982).
Cohen et al., J.P.E.T., 227, 327 (1983) (Cohen I).
Lance, Brit. Med. J., 1970 (2) 327 (Lance I).
Saxena, ibid, 12, 44 (1972).
Lance and Anthony, Proc. Aust. Assoc. Neurol., 7, 32 (1970).
Prusinski et al., Pol. J. Pharmacol. Pharm., 37, Suppl. 189-193.
Harriet F. Lemberger et al., Life Sci., 35, 71 (1984).
Hingten et al., Soc. for Neuroscience Abstract 374, p. 125 (1983).
Cohen Marlene L.
Fuller Ray W.
Garbrecht William L.
Whitten Kathleen R.
Daus Donald G.
Eli Lilly and Company
Martens William C.
Shen Cecilia
Whitaker Leroy
LandOfFree
4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1669029